Moritz J. Strowitzki

1.0k total citations
37 papers, 728 citations indexed

About

Moritz J. Strowitzki is a scholar working on Cancer Research, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Moritz J. Strowitzki has authored 37 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 13 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Moritz J. Strowitzki's work include Cancer, Hypoxia, and Metabolism (14 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Moritz J. Strowitzki is often cited by papers focused on Cancer, Hypoxia, and Metabolism (14 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Moritz J. Strowitzki collaborates with scholars based in Germany, Ireland and United States. Moritz J. Strowitzki's co-authors include Eoin P. Cummins, Cormac T. Taylor, Martin Schneider, Thomas Schmidt, Alexis Ulrich, Markus W. Büchler, Praveen Radhakrishnan, Jonathan M. Harnoss, Leila Sisic and Georg Martin Haag and has published in prestigious journals such as Physiological Reviews, The Journal of Immunology and Annals of Surgery.

In The Last Decade

Moritz J. Strowitzki

34 papers receiving 724 citations

Peers

Moritz J. Strowitzki
Moritz J. Strowitzki
Citations per year, relative to Moritz J. Strowitzki Moritz J. Strowitzki (= 1×) peers Sabrina Rossi

Countries citing papers authored by Moritz J. Strowitzki

Since Specialization
Citations

This map shows the geographic impact of Moritz J. Strowitzki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz J. Strowitzki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz J. Strowitzki more than expected).

Fields of papers citing papers by Moritz J. Strowitzki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritz J. Strowitzki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz J. Strowitzki. The network helps show where Moritz J. Strowitzki may publish in the future.

Co-authorship network of co-authors of Moritz J. Strowitzki

This figure shows the co-authorship network connecting the top 25 collaborators of Moritz J. Strowitzki. A scholar is included among the top collaborators of Moritz J. Strowitzki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritz J. Strowitzki. Moritz J. Strowitzki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vadász, István, Eoin P. Cummins, Deborah H. Brotherton, et al.. (2025). Sensing molecular carbon dioxide: a translational focus for respiratory disease. Physiological Reviews. 105(4). 2657–2691. 1 indexed citations
2.
Niemeyer, C., et al.. (2025). IRE1 is a promising therapeutic target in pancreatic cancer. American Journal of Physiology-Cell Physiology. 328(3). C806–C824. 3 indexed citations
3.
Liese, Juliane, Matthias Hecker, Matthias Wolff, et al.. (2025). Sarcopenia is associated with an unfavorable outcome in patients with acute pancreatitis: A propensity score analysis. Digestive and Liver Disease. 58(1). 96–103. 1 indexed citations
5.
Fitzsimons, Stephen, María Muñoz‐San Martín, Eugène Dillon, et al.. (2023). Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers. Molecular Therapy — Nucleic Acids. 33. 941–959. 1 indexed citations
7.
Mota, Catarina, Moritz J. Strowitzki, Masahiko Shigemura, et al.. (2023). Hypercapnia alters mitochondrial gene expression and acylcarnitine production in monocytes. Immunology and Cell Biology. 101(6). 556–577. 9 indexed citations
8.
Strowitzki, Moritz J., Stephen Fitzsimons, Ilona Uzielienè, et al.. (2022). Carbon Dioxide Sensing by Immune Cells Occurs through Carbonic Anhydrase 2–Dependent Changes in Intracellular pH. The Journal of Immunology. 208(10). 2363–2375. 14 indexed citations
9.
Kennel, Kilian B., Praveen Radhakrishnan, Nathalia A. Giese, et al.. (2022). The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer. JCI Insight. 7(22). 7 indexed citations
10.
Strowitzki, Moritz J., Praveen Radhakrishnan, Jonathan M. Harnoss, et al.. (2021). Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses. JCI Insight. 6(8). 14 indexed citations
11.
Fitzsimons, Stephen, Silvia Oggero, Robyn Bruen, et al.. (2020). microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression. Frontiers in Immunology. 11. 576516–576516. 39 indexed citations
12.
Strowitzki, Moritz J., et al.. (2019). Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?. Pharmacological Research. 147. 104364–104364. 35 indexed citations
13.
Strowitzki, Moritz J., Praveen Radhakrishnan, Florian W. R. Vondran, et al.. (2019). High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases. British Journal of Cancer. 120(7). 675–688. 14 indexed citations
14.
Strowitzki, Moritz J., Johanna Kirchberg, Jonathan M. Harnoss, et al.. (2018). Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells. American Journal Of Pathology. 188(12). 2826–2838. 16 indexed citations
15.
Sisic, Leila, Moritz J. Strowitzki, Susanne Blank, et al.. (2017). Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis. Gastric Cancer. 21(3). 552–568. 35 indexed citations
16.
Rogers, Michael A., Verena Kalter, Moritz J. Strowitzki, Martin Schneider, & Peter Lichter. (2016). IGF2 knockdown in two colorectal cancer cell lines decreases survival, adhesion and modulates survival-associated genes. Tumor Biology. 37(9). 12485–12495. 8 indexed citations
17.
Harnoss, Jonathan M., Jürgen Burhenne, Praveen Radhakrishnan, et al.. (2016). Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth. Annals of Surgery. 265(4). 782–791. 21 indexed citations
18.
Moussavian, Mohammed R., et al.. (2016). Neither Isolated Hepatic Arterial Clamping nor Hepatic Arterial Ligation Induce Ischemic Type Biliary Lesions in Rats. Annals of Transplantation. 21. 649–659. 2 indexed citations
19.
Schneider, Martin, Jonathan M. Harnoss, Moritz J. Strowitzki, et al.. (2015). Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges. PubMed. 3. 1–1. 23 indexed citations
20.
Strowitzki, Moritz J., Stefan Dold, Christina Körbel, et al.. (2014). The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy. Clinical & Experimental Metastasis. 31(7). 795–803. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026